K992127 is an FDA 510(k) clearance for the CARDIOQUANT TROPONIN I TEST. This device is classified as a Immunoassay Method, Troponin Subunit (Class II - Special Controls, product code MMI).
Submitted by Spectral Diagnostics, Inc. (Miami, US). The FDA issued a Cleared decision on October 4, 1999, 103 days after receiving the submission on June 23, 1999.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1215.
| 510(k) Number | K992127 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | June 23, 1999 |
| Decision Date | October 04, 1999 |
| Days to Decision | 103 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | MMI — Immunoassay Method, Troponin Subunit |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.1215 |